June 7 (SeeNews) - Valeant Pharmaceuticals North America, the only candidate to qualify to submit a letter of intent in a tender for Serbian drug maker Galenika, is giving up on the acquisition due to other takeover plans and hostile attitude of Galenika's trade unions, Serbia's finance ministry said on Friday.